Cleared Traditional

K880341 - N-IMMUNOGLOBULIN LIGHT CHAIN KIT

K880341 is the FDA 510(k) clearance for N-IMMUNOGLOBULIN LIGHT CHAIN KIT by Behring Diagnostics, Inc.. It is a Class 2 Immunology device (product code DFH) cleared through the Traditional 510(k) pathway after a 22-day FDA review.

K880341 · Behring Diagnostics, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1988
Decision
22d
Days
Class 2
Risk

K880341 is an FDA 510(k) clearance for the N-IMMUNOGLOBULIN LIGHT CHAIN KIT. Classified as Kappa, Antigen, Antiserum, Control (product code DFH), Class II - Special Controls.

Submitted by Behring Diagnostics, Inc. (Somerville, US). The FDA issued a Cleared decision on February 17, 1988 after a review of 22 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5550 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Behring Diagnostics, Inc. devices

Submission Details

510(k) Number K880341 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 26, 1988
Decision Date February 17, 1988
Days to Decision 22 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
82d faster than avg
Panel avg: 104d · This submission: 22d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DFH Kappa, Antigen, Antiserum, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5550
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DFH Kappa, Antigen, Antiserum, Control

All 39
Devices cleared under the same product code (DFH) and FDA review panel - the closest regulatory comparables to K880341.
BECKMAN KAPPA LIGHT CHAIN REAGENT (ADD'L CLAIMS)
K902484 · Beckman Instruments, Inc. · Jun 1990
BECKMAN LAMBDA LIGHT CHAIN REAGENT
K884597 · Beckman Instruments, Inc. · Dec 1988
BECKMAN KAPPA LIGHT CHAIN REAGENT
K884276 · Beckman Instruments, Inc. · Nov 1988
QM300 KAPPA LIGHT CHAINS ANTIBODY PACK
K875164 · Kallestad Diag, A Div. of Erbamont, Inc. · Jan 1988
QUANTIMETRIC PLUS KAPPA REAGENT KIT
K855008 · Kallestad Laboratories, Inc. · Feb 1986
TISSUE-TEK IMMUNOHISTOLOGY KIT LYSOZZM
K842470 · Miles Laboratories, Inc. · Aug 1984